Delivery Order SPE2DB22D2007-SPE2DB24FH7RV
Award Date 12/6/23
Potential Completion Date 12/28/23
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp has received a $56,490.52 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply REVLIMID 10 MG CAPSULE 28S pharmaceutical products. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified medications to DLA Troop Support Medical facilities in support of military treatment programs. This delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,487.80 by the Defense Logistics Agency on August 28, 2025, for the supply of Revlimid 25 mg capsules (100-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, and will be performed at the awardee's Conshohocken location. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $7,233.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 25 mg capsules (21-count) on January 23, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by February 13, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $33.6K by the Defense Logistics Agency (DLA) on January 29, 2026, for the supply of Revlimid 10 mg capsules (quantity: 28-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by February 20, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's existing Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,281.49 firm fixed price delivery order is for the provision of REVLIMID 25 MG CAPSULE 21S pharmaceutical products. The contract has no set-aside designation and the performance location is Amerisourcebergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $51.7K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units). This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive procurement executed under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of REVLIMID 10 MG Capsules. The award has a ceiling value of $105,612.88 and an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- The Defense Logistics Agency issued a $31,269.57 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for pharmaceutical supply (Revlimid 2.5 mg capsules, 28-count). Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of May 11, 2026. No set-aside was used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier to the Department of Defense and...
- This federal contract award is a delivery order with a ceiling value of $24,963.40 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, with a period of performance through November 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
- <p>The Defense Logistics Agency issued a $41,733.70 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for Revlimid 15 mg capsules (100-count units), with ultimate completion by May 28, 2026.</p> <p>The order is issued under a single-award indefinite delivery contract with the Defense Logistics Agency supporting pharmaceutical supply to military healthcare systems. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>